Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kendall's Tau Test

Kendall's Tau Test

Kendall's tau test, also known as the Kendall rank coefficient test, is a nonparametric method for assessing association between two variables. This test is particularly useful for identifying significant correlations when the distributions of the sample and population are unknown. Developed in 1938 by the British statistician Sir Maurice George Kendall, the tau coefficient (denoted as τ) serves as a rank correlation coefficient, with values ranging from -1 to +1.
A τ value of +1 indicates...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The In Vivo Microstructural Profile of Human Hippocampal Subfield CA1 and Its Relation to Memory Performance.

Human brain mapping·2026

Same author

Dysfunction of the episodic memory network in the Alzheimer's disease cascade.

Nature communications·2026

Same author

Hallmarks of healthy cognitive aging: Inter-individual differences in aging trajectories.

Ageing research reviews·2026

Same author

Beyond the perception of present economic inequality: How people construe past, present and future wealth gaps.

PloS one·2026

Same author

From curiosity to conspiracy: How epistemic motivation shapes competing ways of knowing.

The British journal of social psychology·2026

Same author

Hippocampal-prefrontal connectivity relates to inter-individual differences and training gains in distinguishing similar memories.

Communications biology·2025

Search research articles

Related Experiment Video

Updated: Feb 1, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

Biomarkers for tau pathology.

Michael Schöll¹, Anne Maass², Niklas Mattsson³

¹Wallenberg Centre for Molecular and Translational Medicine and the Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden; Clinical Memory Research Unit, Lund University, Malmö, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.

Molecular and Cellular Neurosciences

|December 12, 2018

Summary

This summary is machine-generated.

Diagnosing neurodegenerative tauopathies is challenging. New biomarkers from cerebrospinal fluid, blood, and PET imaging offer improved detection, diagnosis, and prognosis for these debilitating dementia disorders.

More Related Videos

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Related Experiment Videos

Last Updated: Feb 1, 2026

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Area of Science:

Neuroscience
Biomarker Research
Neurology

Background:

Tauopathies, characterized by tau protein aggregation, are the most common neurodegenerative disorders, causing dementia.
Current diagnostic methods for tauopathies are limited, especially in early disease stages.
Advances in cerebrospinal fluid (CSF) and blood tau measurements have improved understanding, but blood biomarker significance is still under investigation.

Purpose of the Study:

To review the current state of tau biomarkers in neuroimaging and bodily fluids.
To discuss the role of these biomarkers in the detection, diagnosis, and prognosis of tau-associated neurodegenerative disorders.
To provide a perspective on the future clinical and research applications of tau biomarkers.

Main Methods:

Review of existing literature on tau biomarkers.
Analysis of fluid biomarkers (CSF and blood).
Evaluation of neuroimaging techniques, specifically positron emission tomography (PET) ligands for tau pathology.

Main Results:

Cerebrospinal fluid (CSF) tau measurements are crucial for diagnosing tauopathies.
Positron emission tomography (PET) ligands enable in vivo visualization and quantification of tau pathology in the brain.
The combined use of fluid biomarkers and PET imaging forms a key area of active research.

Conclusions:

Tau biomarkers from both fluid analysis and neuroimaging are vital for advancing the diagnosis and understanding of tauopathies.
Further research is needed to clarify the role of blood-based tau biomarkers.
Prospective application of these biomarkers holds promise for improved clinical management and research in neurodegenerative disorders.